Rapid Micro Biosystems Announces Record Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue
Fourth quarter 2025 total revenue expected to be approximately $11.3 million, representing growth of approximately 37% compared to the prior-year period.Received record multi-system order in the fourth quarter from an existing Top 20 global biopharma customer to automate global manufacturing network.Full year 2025 total revenue expected to be approximately $33.6 million, representing growth of approximately 20% compared to the prior year. LEXINGTON, Mass., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosy ...